{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:59:50Z","timestamp":1781495990595,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.cmi.2016.10.019","type":"journal-article","created":{"date-parts":[[2016,10,26]],"date-time":"2016-10-26T07:02:15Z","timestamp":1477465335000},"page":"179-187","source":"Crossref","is-referenced-by-count":9,"title":["Benzylpenicillin plus an aminoglycoside versus meropenem in neutropenic lymphoma and leukaemia patients with a suspected bacterial infection: a randomized, controlled trial"],"prefix":"10.1016","volume":"23","author":[{"given":"D.","family":"Torfoss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Fladhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Holte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Brinch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.H.","family":"Schjesvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Fl\u00f8isand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Nyquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dalgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hammerstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Skjelbakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"H\u00f8iby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sandvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kval\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2016.10.019_bib1","series-title":"Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway","author":"NORM\/NORM-VET 2011","year":"2012"},{"key":"10.1016\/j.cmi.2016.10.019_bib2","series-title":"Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway","author":"NORM\/NORM-VET 2015","year":"2016"},{"key":"10.1016\/j.cmi.2016.10.019_bib3","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1093\/jac\/dkr361","article-title":"Increased antibiotic use in Norwegian hospitals despite a low antibiotic resistance rate","volume":"66","author":"Haug","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2016.10.019_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(00)90015-1","article-title":"An antibiotic policy to prevent emergence of resistant bacilli","volume":"355","author":"de Man","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.cmi.2016.10.019_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jac\/dkm003","article-title":"Tobramycin once versus three times daily, given with penicillin G, to febrile neutropenic cancer patients in Norway: a prospective, randomized, multicentre trial","volume":"59","author":"Torfoss","year":"2007","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2016.10.019_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3109\/0284186X.2011.633931","article-title":"The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review","volume":"51","author":"Torfoss","year":"2012","journal-title":"Acta Oncol"},{"key":"10.1016\/j.cmi.2016.10.019_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/137.1.14","article-title":"The EORTC, International Antimicrobial Therapy Project Group. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer","volume":"137","year":"1978","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2016.10.019_bib8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1200\/JCO.1983.1.10.597","article-title":"Combination of amikacin and carbencillin with or without cefazolin as empirical treatment of febrile neutropenic patients","volume":"1","year":"1983","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cmi.2016.10.019_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/AAC.29.2.263","article-title":"Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients","volume":"29","author":"Klastersky","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2016.10.019_bib10","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJM198712313172703","article-title":"Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia","volume":"317","author":"The EORTC, International Antimicrobial Therapy Cooperative Group","year":"1987","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl.1","key":"10.1016\/j.cmi.2016.10.019_bib11","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/S0959-8049(05)80253-9","article-title":"Empirical antibiotic therapy in neutropenic cancer patients","volume":"29A","author":"Klastersky","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cmi.2016.10.019_bib12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.40.5.1108","volume":"40","author":"Cometta","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2016.10.019_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jac\/dki448","article-title":"Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials","volume":"57","author":"Paul","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2016.10.019_bib14","first-page":"CD003038","article-title":"Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia","author":"Paul","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cmi.2016.10.019_bib15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4065\/80.9.1122","article-title":"Systematic review and meta-analysis of febrile neutropenia [editorial]","volume":"80","author":"Paul","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cmi.2016.10.019_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","article-title":"Pharmacokinetic\/pharmacodynamic parameters: rationale for antimicrobial dosing in mice and men","volume":"26","author":"Craig","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2016.10.019_bib17","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1086\/344650","article-title":"Methodology for clinical trials involving patients with cancer who have febrile neutropenia: updated guidelines of the Immunocompromised Host Society\/Multinational Association for Supportive Care in Cancer, with emphasis on outpatient studies","volume":"35","author":"Feld","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2016.10.019_bib18","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0895-4356(91)90008-W","article-title":"Relating patient characteristics at the time of admission to outcomes of hospitalization","volume":"44","author":"Pompei","year":"1991","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.cmi.2016.10.019_bib19","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","article-title":"The Multinational Association for Supportive Care in Cancer Risk Index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients","volume":"18","author":"Klastersky","year":"2000","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cmi.2016.10.019_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jac\/dkq451","article-title":"Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and metaanalysis","volume":"66","author":"Mavros","year":"2011","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2016.10.019_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jac\/dkr425","article-title":"Ethical dilemmas in antibiotic treatment","volume":"67","author":"Leibovici","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16305080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X16305080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T01:38:50Z","timestamp":1568511530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X16305080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1198743X16305080"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2016.10.019","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}